ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0700

Prospective Evaluation of Capillaroscopy in Healthy Children

Tessa Dufour1, Maurizio Cutolo2, Dieneke Schonenberg-Meinema3, Kaat Wyckstandt4, Adela Sarbu5, joke dehoorne6, Steven Wallaert7 and vanessa smith8, 1University Hospital Ghent, Gent, Belgium, 2Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Ospedale Policlinico San Martino, Genoa, Italy, Genova, Italy, 3Amsterdam University Medical Center, Amsterdam, Netherlands, 4University Hospital Ghent, Ghent, Belgium, 5University hospital Bern, Bern, Switzerland, 6University Hospital Ghent, Ghent, 7Ghent University, Ghent, Belgium, 8Ghent University Hospital, Gent, Belgium

Meeting: ACR Convergence 2024

Keywords: Pediatric rheumatology, Raynaud's, Scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Capillaroscopy is a well-established tool in the diagnosis of adult-onset rheumatic diseases and global consensus on standardisation of execution and interpretation performing capillaroscopy  have been  published.  Recently, the first multicentre cross-sectional study evaluated capillaroscopic findings in children with  rheumatic diseases and healthy controls. However, there have been no longitudinal studies.

Methods: Sixty-nine healthy schoolchildren underwent two capillaroscopies with a mean interval of 3.8 years. A standardized NVC technique with a 200x magnification lens was used on all fingers, except for the thumbs. Two images were captured per nailfold on which a 1mm grid was placed. The quantitative and qualitative analysis of capillaroscopic images was performed according to the EULAR Study Group on Microcirculation in Rheumatic Diseases consensus1. Descriptive statistics were performed. Different generalized linear mixed models (GLMMs) were used to model the mean density, mean apical diameter, mean number of dilatations and abnormal shapes, and the probability of microhaemorrhages. A Bonferroni correction for multiplicity by setting the confidence level to 99.5% was executed.

Results: Demographics are shown in Table 1. A statistical significant difference was observed for capillary density between visit 1 and 2 according to age with a stronger increase in density for younger ages (p = 0.004). However, the mean difference remained small (< 1 capillary/linear mm), showing no clinical difference (Figure 1A). There was no statistical significant difference in density between genders (p = 0.368) nor in the mean number of dilatations and abnormal shapes between visit 1 and 2 (p = 0.615; p = 0.811) (Figure 1B-C). A statistical significant difference in presence of haemorrhages between visits was found (p< 0.001), adjusted for trauma (p=0.680) (Figure 1D).

At visit 1 none of the healthy children had a scleroderma pattern, 13% a stereotype normal and 87% non-specific changes. At visit 2, 1 child had a scleroderma pattern, 10.1% a stereotype normal and 88.4% non-specific changes.

Conclusion: This study suggests that there is no clinically significant difference in capillaroscopic findings over time in healthy children without Raynaud’s phenomenon. There seems to be a higher prevalence of non-specific patterns compared to healthy adults. Also in healthy children, a scleroderma pattern is rare. A large multicentre study through EULAR is being executed to validate these results.

Supporting image 1

Supporting image 2

Figure 1. Capillaroscopic features of healthy children at visit 1 and 2. (A) Mean capillary density in healthy children according to age at visit 1 and 2; (B) Mean number of dilatations per linear mm in healthy children according to age at visit 1 and 2; (C) Mean number of abnormal shapes per linear mm in healthy children according to age at visit 1 and 2; (D) Presence of haemorrhages in healthy children at visit 1 and 2.


Disclosures: T. Dufour: None; M. Cutolo: AbbVie/Abbott, 5, Amgen, 5, Balcacci, 2, 5, Boehringer-Ingelheim, 2, 5, Bristol-Myers Squibb(BMS), 2, 5, UCB, 5; D. Schonenberg-Meinema: None; K. Wyckstandt: None; A. Sarbu: None; j. dehoorne: None; S. Wallaert: None; v. smith: Argenx, 2, BKC Moving Media Makers, 6, Boehringer-Ingelheim, 2, 5, 6, Janssen, 2, 5, 6, WebMDD Global LLC, 2.

To cite this abstract in AMA style:

Dufour T, Cutolo M, Schonenberg-Meinema D, Wyckstandt K, Sarbu A, dehoorne j, Wallaert S, smith v. Prospective Evaluation of Capillaroscopy in Healthy Children [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/prospective-evaluation-of-capillaroscopy-in-healthy-children/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prospective-evaluation-of-capillaroscopy-in-healthy-children/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology